EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

EFFECT OF DIENOGEST AND MEDROXYPROGESTERONE ACETATE (MPA) ON QUALITY OF LIFE IN ENDOMETRIOSIS: A COMPARATIVE STUDY

Dr. Amiya*, Dr. Jyoti Kaushal and Dr. Savita Rani Singhal

ABSTRACT

Introduction: Endometriosis is common in reproductive women usually between 15 to 49 years age characterized by clinical symptoms like dysmenorrhea, chronic pelvic pain, dyspareunia, dyschezia, irregular uterine bleeding and infertility which can severely affect a woman's quality of life (QOL). This study was done to observe improvement in quality of life after treatment with dienogest versus medroxyprogesterone acetate (MPA) in women with endometriosis. Materials & Methods: A prospective, randomized, comparative clinical study was conducted on 60 patients and they were randomly divided in two groups of 30 each to receive either Dienogest 2 mg OD (Group A) or Medroxyprogesterone acetate 10 mg BD (Group B) orally for 12 weeks. Quality of life assessment was done using Endometriosis health profile-30 (EHP-30) Questionnaire. Results: At the end of 12 weeks, there was reduction in the scores of all the domains of QOL with both the drugs i.e. pain domain, control & powerlessness domain, emotion domain, social support domain and self-image domain in dienogest group (79.19%, 74.82%, 77.82%, 68.99% and 53.96%) and MPA group (61.86%, 62.58%, 61.30%, 54.48% and 19.03%) respectively as compared to baseline values. On intergroup analysis, dienogest showed statistically significant better response than MPA in reduction of pain & emotional domain (p=0.004 & p=0.012 respectively). Conclusion: Although there was a definite improvement in QOL with both types of treatment in women with endometriosis but on comparing both the groups, dienogest showed more improvement in QOL than MPA especially in pain & emotional domain.

Keywords: Dienogest, medroxyprogesterone acetate, endometriosis, quality of life, endometriosis health profile-30, progestin.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MARCH ISSUE PUBLISHED

    MARCH 2024 issue has been successfully launched on MARCH 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia